Labshake search
Citations for R&D Systems :
2401 - 2450 of 3306 citations for Human Phosphatidic Acid Phosphatase Type 2A PPAP2A ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2024Quote: ... along with 50 ng/ml recombinant human GDNF (R&D Systems, 212-GD-010) were administered for 12 hr ...
-
bioRxiv - Bioengineering 2024Quote: ... 20 ng/mL human basic fibroblast growth factor (b-FGF) (R&D Systems, Inc.), and 10 μM Y27632 (FUJIFILM Wako Pure Chemical Corporation ...
-
bioRxiv - Bioengineering 2024Quote: ... which was supplemented with 10 ng/mL human activin A (R&D Systems, Inc.), 5 ng/mL human Bmp4 (R&D Systems ...
-
bioRxiv - Biochemistry 2024Quote: Human recombinant CatA was first activated by following the manufacturer’s instructions (R&D Systems), incubating at 37°C 10 µg/mL CatA with 1 µg/mL CatL in an activation buffer (25 mM MES pH = 6.0 ...
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human or murine Fc-ICAM-1 (10 μg/ml) (R&D Systems) coated plates ...
-
bioRxiv - Developmental Biology 2024Quote: ... supplemented with 1 ng/ml human Activin A (R&D Systems Cat#. 338-AC) and 1 ng/ml human BMP4 (R&D Systems Cat# 314-BP) ...
-
bioRxiv - Immunology 2024Quote: ... 2mM L-Glutamine and 20ng/mL of recombinant human IL-3 (R&D systems). Cas9 and gRNA components were assembled into RNP per the manufacturer’s instructions and transfected into pDC 16 hrs p.c ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 μM Y-27632 and 2 ng/mL human recombinant BMP4 (R&D Systems) and then cultured in ultra-low attachment 6 well plate (Corning ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/ml recombinant human M-CSF (R&D Systems 216-MC-100) at 37°C for seven days.
-
bioRxiv - Microbiology 2023Quote: ... and goat anti-human angiotensin converting enzyme 2 (ACE2; R&D Systems; 1:500). Appropriate species-specific secondary antibodies conjugated to AlexaFluor555 and/or AlexaFluor647 were applied for fluorescent detection ...
-
bioRxiv - Microbiology 2023Quote: ... Recombinant human Wnt-3a (rhWnt-3a) (#5036-WN, R&D Systems; Minneapolis, Minnesota, USA) was resuspended according to manufacturer’s instructions and stored at −80°C.
-
ANGPTL8 R59W variant influences inflammation through modulating NF-κB pathway under TNFα stimulationbioRxiv - Biochemistry 2023Quote: ... the cells were treated with Recombinant Human TNFα Protein (R&D Systems, MN, USA) at 25ng/mL for 18 hours ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Cancer Biology 2023Quote: ... and Alexa Fluor 750-conjugated human ALCAM/CD166 (R&D Systems, Minneapolis, MN, USA). Sytox Red Dead Cell Stain (ThermoFisher Scientific ...
-
bioRxiv - Neuroscience 2023Quote: ... Cells were then incubated overnight with human PRL (R&D Systems, 682-PL-050)
-
bioRxiv - Neuroscience 2023Quote: ... and goat anti-human HB-EGF (R&D Systems, AF-259-NA; 1:40). Secondary antibodies were Alexa Fluor 488 and Alexa Fluor 594 donkey anti-rabbit and donkey anti-goat (all Life Technologies ...
-
bioRxiv - Genetics 2023Quote: ... and recombinant human FGF2 at 20 ng/uL (R&D systems #233-FB-010).
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL of recombinant human IL-17B (R&D Systems, Minneapolis, MN) for 48 h and processed for downstream RNA expression analysis ...
-
bioRxiv - Biochemistry 2023Quote: ... we used commercial recombinant human OGT fragment (Cys323-Glu1041) (R&D systems, 8446-GT). Thereafter ...
-
bioRxiv - Cancer Biology 2023Quote: ... 200ng/mL recombinant Human Wnt3a (R&D System, Cat. No. 5036-WN-010/CF) or Wnt5a (R&D System ...
-
bioRxiv - Immunology 2023Quote: ... and 1 ng/ml recombinant human basic fibroblast growth factor (bFGF)(R&D Systems). Human MSCs were obtained from ATCC (catalog #PCS-500-012 ...
-
bioRxiv - Immunology 2023Quote: ... cells were incubated with 10μg/ml human anti-TNFR1 (clone 16805) (R&D System), 20μg/ml human anti-IFNGR1 (clone GIR208 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were incubated with anti-human CCR2-biotin (FAB151B; R&D Systems/ 357224; BioLegend) in FACS buffer (HBSS ...
-
bioRxiv - Immunology 2023Quote: ... and the human/mouse anti-BMP9 antibody (#AF3209) were purchased from R&D Systems. Recombinant human IFNβ was purchased from PeproTech (#300-02BC) ...
-
bioRxiv - Immunology 2023Quote: ... or goat anti-human LDLR at a 1:500 dilution (AF2148; R&D Systems) followed by incubation with an anti-goat IgG horseradish peroxidase-conjugated secondary antibody at a 1:1000 dilution (HAF107 ...
-
bioRxiv - Cell Biology 2023Quote: ... and Human/Mouse/Rat/Chicken anti-PAX7 antibody (MAB1675, R&D Systems, 5μg/ml), both diluted 1:100 ...
-
bioRxiv - Bioengineering 2023Quote: ... 1.5 mL CDM with 6 ng/mL human recombinant activin A (R&D Systems) and 5 ng/mL bFGF (R&D Systems ...
-
bioRxiv - Biochemistry 2023Quote: Recombinant human angiogenin (catalog number 265-AN/CF) was purchased from R&D Systems, a Bio-Techne Company (Minneapolis ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 20 ng/mL of recombinant human oncostatin M (OSM, R&D systems). For the co-culture experiment ...
-
bioRxiv - Cell Biology 2024Quote: ... SHBG levels were quantified using the Human XL Cytokine Discovery Panel (R&D systems). Assays were completed according to the manufacturer’s instructions at The University of Pittsburgh Cancer Proteomics Facility Luminex® Core Laboratory on the xMAP platform ...
-
bioRxiv - Cancer Biology 2024Quote: Primary human AML cells were plated in cytokine-enriched methylcellulose (R&D Systems HSC005) in triplicate ...
-
bioRxiv - Molecular Biology 2024Quote: ... with or without 1 ng/mL recombinant human BMP9 (R&D Systems, Minneapolis, MN) for an additional 24 hours ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-7 (rh IL-7; R&D Systems). PBMCs treated with 0.1ug/mL of SEB were supplemented with 10ng/mL of rh IL-7 alone ...
-
bioRxiv - Neuroscience 2021Quote: ... coated plates in N4 media (N3 with 0.05uM Retinoic acid, 2ng/ml BDNF (R&D Systems #248-BDB) and 2 ng/ul GDNF (R&D Systems #212-GD)) ...
-
bioRxiv - Neuroscience 2019Quote: ... The TNF-α concentration in the supernatant was quantified using the Duoset® enzyme-linked immunosorbent assay (ELISA) development system (R&D Systems, Abingdon, Oxfordshire, UK). Three wells for each CSF were used to estimate variation in the experiments ...
-
bioRxiv - Cell Biology 2020Quote: Supernatant of confluent pulmonary endothelial cells were analyzed for TNF-α and IL-6 by using a mouse-specific ELISA from R&D Systems (Minneapolis, MN, USA) according to manufacturer’s protocol with the help of an Infinite M200 PRO plate reader (TECAN Instruments ...
-
bioRxiv - Immunology 2020Quote: IL-1β and CXCL9 were measured using ELISA (IL-1β from cell culture supernatants: MLB00C, R&D Systems; IL-1β from serum: MHSLB00, R&D Systems; CXCL9: DY492, R&D Systems), G-CSF ...
-
bioRxiv - Cell Biology 2023Quote: ... Concentrations of IL33 and periostin in culture supernatants were measured by ELISA according to the manufacturer’s instructions (Invitrogen, cat #: BMS2048TEN, Carlsbad, CA, USA; R&D Systems, cat #: DY3548B, Minneapolis, MN, USA) and as described previously [10] ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems, #233-FB-025).
-
bioRxiv - Biochemistry 2020Quote: ... Western blotting was performed with antibodies against human ANG (goat, R&D systems; 1:300), β-actin (rabbit ...
-
bioRxiv - Neuroscience 2020Quote: ... or with human NogoA (566-748aa) and Fc chimera protein (Nogo-Δ20; R&D Systems), for 10m ...
-
bioRxiv - Bioengineering 2021Quote: Recombinant human IDO expressed in Escherichia coli was purchased from R&D Systems (Minneapolis, MN) with a predicted molecular mass of 46 kDa a specific activity of >500pmoles/min/μg (or for equimolar calculations >29 pmol NFK/min/pmol IDO ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml IL6 + 0.1 ng/ml recombinant human sgp130-Fc (R&D Systems, Germany) or 20 ng/ml Hyper-IL6 (kind gift of S ...
-
bioRxiv - Microbiology 2020Quote: ... infected HFF monolayers were stimulated with 100U/mL recombinant human IFN-γ (R&D Systems) 24 hours post-infection and fixed 6 hours post-stimulation ...
-
bioRxiv - Cancer Biology 2020Quote: ... CMK lines were treated with 200 ng/ml of recombinant human WNT3A (R&D systems) for 4 hours ...
-
bioRxiv - Cancer Biology 2020Quote: ... mouse or rat collagen I (human, R&D Systems; mouse, Ray Biotech; rat, Yo Protein) or collagen III (human ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 ng ml−1 of recombinant human TNFα (R&D Systems, 210-TA-020/CF) or a combination of both ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 ng/ml recombinant human NRG1-β 1 (#396-HB, R&D Systems, USA) as described in Poitelon et al ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...